Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ability, Acepodia, Aicuris, Alphamab Oncology, Applied Biomath, Azitra, BMS, Brainstorm Cell, Canbridge, Cardiff, Chelation, Cn, Cortexyme, Debiopharm, Destiny, Fujifilm, IGY Immune, Isoplexis, Kalytera, Leading Biosciences, Meabco, Nanomab, Nanoviricides, Oncology Ventures, Ose, Pharmamar, Royalty Pharma, Sanofi, Sensorion, Serimmune, Theracour, Thermogenesis, TTY, Twist, Ubivac, Valneva, Verity.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Astellas, Astrazeneca, Bergenbio, Celltrion, CSL Behring, Eli Lilly, Fibrogen, Innovent, Inovio, Junshi, Kiniksa, Neurorx, Novartis, Relief, Sosei, Takeda.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Agenus, Algernon, Arch, Beigene, Cellenkos, Clarity, Elixirgen, FSD, Helsinn, Kiniksa, Lupin, Mylan, Oncolys, Revive, Specialised, Taiho, Trevena.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: 4Bio Ventures, A2A, Abbvie, AGC, Alivamab Discovery, Arbor, Astrazeneca, Avita Medical, Black Cat, Cresco, CSL, Delta 4, East China Normal University, Eleva, Epivax, Exeltis Healthcare, Global Institute of Stem Cell Therapy and Research, Harbour Biomed, Healios, Heat Biologics, Ibio, Immunoprecise Antibodies, Integrated, Intravacc, Kyowa Kirin, Laxai Life Sciences, Lupin, Macure, Memo, Mitsubishi Tanabe, Modular, Novavax, Octapharma, Oncolytika, Pharmabcine, Rottapharm, Sorrento, Swift, Takis, Valirx, Vitro Diagnostics.

Biopharmas in Asia-Pacific raising money in public or private financings, including: Apeiron, Appili, Bionomics, Fujifilm Toyama Chemical, Gilead Sciences, Humanigen, Outlook.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Agios Pharmaceuticals, Applied DNA Sciences, Biosensors International, Blue Sail Medical, Cepheid, Cytosorbents, Endovantage, Gene-IQ, Isoplexis, Makemedical, Mallinckrodt, Naglreiter Consulting, Nvt, RapidAI, Thermo Fisher, Titan Medical, Veracyte, Xoran Technologies.

Med-tech firms raising money in public or private financings, including: C2i Genomics, Caredx, DNAnexus, Patientping.

New hires and promotions in the med-tech industry, including: Boston Microfluidics, Hesperos, Lindacare.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Agios, Global Blood Therapeutics, Immune, Immunic, Immuron, Revive, Saniona.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aurinia, Beyondspring, Can-Fite, Dermavant, Dynavax, Erytech, Fibrogen, Karyopharm, Lilly, Nanology, Nflection, Oncosec, Opko, Renibus, Resverlogix, Revolution Medicines, Soleno, Soricimed, Vedanta.